193 related articles for article (PubMed ID: 35407611)
1. Embolic Protection with the TriGuard 3 System in Nonagenarian Patients Undergoing Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis.
Lind A; Jánosi RA; Totzeck M; Ruhparwar A; Rassaf T; Al-Rashid F
J Clin Med; 2022 Apr; 11(7):. PubMed ID: 35407611
[TBL] [Abstract][Full Text] [Related]
2. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Difference in Post-procedural Stroke Rates Between Patients with Aortic Stenosis Who Undergo Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement.
Burke H; Boron A; Lee JH; Kahlon KR
Cureus; 2018 Apr; 10(4):e2494. PubMed ID: 29922535
[TBL] [Abstract][Full Text] [Related]
4. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement.
Yashima F; Briasoulis A; Kuno T; Noguchi M; Ahmad H; Zaid S; Goldberg JB; Malik AH; Tang GHL
Cardiovasc Revasc Med; 2022 Mar; 36():9-13. PubMed ID: 34024747
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Cerebral Embolic Protection Devices on Characteristics and Outcomes of Stroke Complicating TAVR.
Levi A; Linder M; Seiffert M; Witberg G; Pilgrim T; Tomii D; Barkan YT; Van Mieghem NM; Adrichem R; Codner P; Hildick-Smith D; Arunothayaraj S; Perl L; Finkelstein A; Loewenstein I; De Backer O; Barnea R; Tarantini G; Fovino LN; Vaknin-Assa H; Mylotte D; Wagener M; Webb JG; Akodad M; Colombo A; Mangieri A; Latib A; Kargoli F; Giannini F; Ielasi A; Søndergaard L; Aviram I; Lerman TT; Kheifets M; Auriel E; Kornowski R;
JACC Cardiovasc Interv; 2024 Mar; 17(5):666-677. PubMed ID: 38479966
[TBL] [Abstract][Full Text] [Related]
6. TriGuard
Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
[TBL] [Abstract][Full Text] [Related]
7. Comparative meta-analysis of balloon-expandable and self-expandable valves for transcatheter aortic valve replacement.
Agarwal S; Parashar A; Kumbhani DJ; Svensson LG; Krishnaswamy A; Tuzcu EM; Kapadia SR
Int J Cardiol; 2015 Oct; 197():87-97. PubMed ID: 26117654
[TBL] [Abstract][Full Text] [Related]
8. Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.
Campelo-Parada F; Regueiro A; Dumont E; DeLarochellière R; Paradis JM; Mohammadi S; Doyle D; Rodés-Cabau J
J Card Surg; 2016 Oct; 31(10):617-622. PubMed ID: 27577965
[TBL] [Abstract][Full Text] [Related]
9. Self-expandable transcatheter aortic valve replacement is associated with frequent periprocedural stroke detected by diffusion-weighted magnetic resonance imaging.
Kajio K; Mizutani K; Hara M; Nakao M; Okai T; Ito A; Takahashi Y; Iwata S; Shimono T; Izumiya Y; Murakami T; Shibata T; Yoshiyama M
J Cardiol; 2019 Jul; 74(1):27-33. PubMed ID: 30795938
[TBL] [Abstract][Full Text] [Related]
10. Alternative Access Versus Transfemoral Transcatheter Aortic Valve Replacement in Nonagenarians.
Stamou SC; Lin N; James T; Rothenberg M; Lovitz L; Faber C; Kapila A; Nores MA
J Invasive Cardiol; 2019 Jun; 31(6):171-175. PubMed ID: 30982779
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
[TBL] [Abstract][Full Text] [Related]
12. Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration.
Vlastra W; Chandrasekhar J; Vendrik J; Gutierrez-Ibanes E; Tchétché D; de Brito FS; Barbanti M; Kornowski R; Latib A; D'Onofrio A; Ribichini F; Baan J; Tijssen JGP; Pan M; Dumonteil N; Mangione JA; Sartori S; D'Errigo P; Tarantini G; Lunardi M; Orvin K; Pagnesi M; Sanchez Gila J; Modine T; Dangas G; Mehran R; Piek JJ; Delewi R
JACC Cardiovasc Interv; 2019 May; 12(10):911-920. PubMed ID: 31122347
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of minimalist approach in transfemoral transcatheter aortic valve replacement: insights from the Optimized transCathEter vAlvular interventioN-Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry.
Hosoba S; Yamamoto M; Shioda K; Sago M; Koyama Y; Shimura T; Kagase A; Tada N; Naganuma T; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):420-424. PubMed ID: 29096029
[TBL] [Abstract][Full Text] [Related]
14. Cerebral embolic protection device utilization and outcomes in transcatheter aortic valve replacement: A nationally representative propensity matched analysis.
Altibi AM; Alhuneafat L; Jabri A; Al-Abdouh A; Ghanem F
Cardiovasc Revasc Med; 2024 Apr; ():. PubMed ID: 38653674
[TBL] [Abstract][Full Text] [Related]
15. The Role of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement.
Demir OM; Iannopollo G; Mangieri A; Ancona MB; Regazzoli D; Mitomo S; Colombo A; Weisz G; Latib A
Front Cardiovasc Med; 2018; 5():150. PubMed ID: 30406115
[TBL] [Abstract][Full Text] [Related]
16. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.
Blackstone EH; Suri RM; Rajeswaran J; Babaliaros V; Douglas PS; Fearon WF; Miller DC; Hahn RT; Kapadia S; Kirtane AJ; Kodali SK; Mack M; Szeto WY; Thourani VH; Tuzcu EM; Williams MR; Akin JJ; Leon MB; Svensson LG
Circulation; 2015 Jun; 131(22):1989-2000. PubMed ID: 25832034
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I Trial.
Thourani VH; Jensen HA; Babaliaros V; Kodali SK; Rajeswaran J; Ehrlinger J; Blackstone EH; Suri RM; Don CW; Aldea G; Williams MR; Makkar R; Svensson LG; McCabe JM; Dean LS; Kapadia S; Cohen DJ; Pichard AD; Szeto WY; Herrmann HC; Devireddy C; Leshnower BG; Ailawadi G; Maniar HS; Hahn RT; Leon MB; Mack M
Ann Thorac Surg; 2015 Sep; 100(3):785-92; discussion 793. PubMed ID: 26242213
[TBL] [Abstract][Full Text] [Related]
18. Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.
Kapadia SR; Huded CP; Kodali SK; Svensson LG; Tuzcu EM; Baron SJ; Cohen DJ; Miller DC; Thourani VH; Herrmann HC; Mack MJ; Szerlip M; Makkar RR; Webb JG; Smith CR; Rajeswaran J; Blackstone EH; Leon MB;
J Am Coll Cardiol; 2018 Nov; 72(20):2415-2426. PubMed ID: 30442284
[TBL] [Abstract][Full Text] [Related]
19. Cerebral embolic protection during transcatheter heart interventions.
Jimenez Diaz VA; Kapadia SR; Linke A; Mylotte D; Lansky AJ; Grube E; Settergren M; Puri R
EuroIntervention; 2023 Sep; 19(7):549-570. PubMed ID: 37720969
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter aortic valve replacement in nonagenarians: early and intermediate outcome from the OBSERVANT study and meta-analysis of the literature.
Biancari F; D'Errigo P; Rosato S; Pol M; Tamburino C; Ranucci M; Seccareccia F
Heart Vessels; 2017 Feb; 32(2):157-165. PubMed ID: 27251569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
